BRPI0912136A2 - métodos para diagnosticar proliferação peroxissomal aumentada e para identificar uma substância para tratar proliferação peroxissomal aumentada, e, uso de pelo menos cinco analitos e de meios para a determinação de pelo menos cinco analitos - Google Patents

métodos para diagnosticar proliferação peroxissomal aumentada e para identificar uma substância para tratar proliferação peroxissomal aumentada, e, uso de pelo menos cinco analitos e de meios para a determinação de pelo menos cinco analitos

Info

Publication number
BRPI0912136A2
BRPI0912136A2 BRPI0912136A BRPI0912136A BRPI0912136A2 BR PI0912136 A2 BRPI0912136 A2 BR PI0912136A2 BR PI0912136 A BRPI0912136 A BR PI0912136A BR PI0912136 A BRPI0912136 A BR PI0912136A BR PI0912136 A2 BRPI0912136 A2 BR PI0912136A2
Authority
BR
Brazil
Prior art keywords
peroxismal
analytes
proliferation
increased
identifying
Prior art date
Application number
BRPI0912136A
Other languages
English (en)
Inventor
Alexandre Prokoudine
Bennard Van Ravenzwaay
Edgar Leibold
Eric Fabian
Georgia Coelho Palermo Cunha
Hennicke Kamp
Jan C Wiemer
Michael Manfred Herold
Ralf Looser
Tilmann B Walk
Volker Strauss
Werner Mellert
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of BRPI0912136A2 publication Critical patent/BRPI0912136A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0027—Methods for using particle spectrometers
    • H01J49/0036—Step by step routines describing the handling of the data generated during a measurement
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/046—Thyroid disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0912136A 2008-05-28 2009-05-26 métodos para diagnosticar proliferação peroxissomal aumentada e para identificar uma substância para tratar proliferação peroxissomal aumentada, e, uso de pelo menos cinco analitos e de meios para a determinação de pelo menos cinco analitos BRPI0912136A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08157118 2008-05-28
EP09151549 2009-01-28
PCT/EP2009/056386 WO2009153139A2 (en) 2008-05-28 2009-05-26 Means and methods for assessing increased peroxisomal proliferation

Publications (1)

Publication Number Publication Date
BRPI0912136A2 true BRPI0912136A2 (pt) 2015-11-03

Family

ID=41213166

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912136A BRPI0912136A2 (pt) 2008-05-28 2009-05-26 métodos para diagnosticar proliferação peroxissomal aumentada e para identificar uma substância para tratar proliferação peroxissomal aumentada, e, uso de pelo menos cinco analitos e de meios para a determinação de pelo menos cinco analitos

Country Status (9)

Country Link
US (3) US8658427B2 (pt)
EP (1) EP2286245A2 (pt)
JP (1) JP5584680B2 (pt)
CN (1) CN102105797A (pt)
AU (1) AU2009259543B2 (pt)
BR (1) BRPI0912136A2 (pt)
CA (1) CA2724422A1 (pt)
DE (1) DE112009001301T5 (pt)
WO (1) WO2009153139A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2286245A2 (en) * 2008-05-28 2011-02-23 Basf Se Means and methods for assessing increased peroxisomal proliferation
JP5866287B2 (ja) * 2009-10-02 2016-02-17 メタボロン，インコーポレイテッド 複雑な混合物における小分子成分分析のための装置及び関連する方法
EP2529235B1 (en) 2010-01-29 2019-03-06 Metanomics GmbH Means and methods for diagnosing heart failure in a subject
BR112014004761A2 (pt) * 2011-09-14 2017-03-21 Basf Se método para diagnosticar toxicidade gonadal, para determinar se um composto é capaz de induzir toxicidade gonadal em um indivíduo, para identificação de uma subtância para tratar toxicidade gonadal, uso de pelo menos um biomarcador, dispositivo para diagnosticar toxicidade gonadal em uma amostra de um indivíduo com suspeita de sofrer da mesma e kit para diagnosticar toxicidade gonadal
JP2014530350A (ja) * 2011-09-14 2014-11-17 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 腎臓毒性を評価するための手段及び方法
EP2815236A4 (en) * 2012-02-15 2015-11-04 Basf Se MEANS AND METHODS FOR ASSESSING ENDOCRINE DISEASE OR ENDOCRINE DISORDER
US20150044702A1 (en) * 2012-03-09 2015-02-12 Basf Se Means and methods for assessing disorders related to impaired iron adsorption or energy metabolism
EP2822455A4 (en) * 2012-03-09 2015-12-09 Basf Se MEDIUM AND METHOD FOR ASSESSING LIVER DISORDERS
CN112798771B (zh) * 2021-03-31 2021-07-30 宝枫生物科技（北京）有限公司 用于诊断脑白质病变的生物标志物及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540884A (en) 1982-12-29 1985-09-10 Finnigan Corporation Method of mass analyzing a sample by use of a quadrupole ion trap
US5397894A (en) 1993-05-28 1995-03-14 Varian Associates, Inc. Method of high mass resolution scanning of an ion trap mass spectrometer
EP1129351A2 (en) * 1998-11-13 2001-09-05 Curagen Corporation COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-$g(a) MEDIATED PATHWAY
US6372431B1 (en) * 1999-11-19 2002-04-16 Incyte Genomics, Inc. Mammalian toxicological response markers
ATE386986T1 (de) * 2001-07-06 2008-03-15 Lipomics Technologies Inc Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten
EP1438420B1 (en) 2001-09-24 2009-09-16 Lipomics Technologies, Inc. Methods of using quantitative lipid metabolome data
WO2005026727A1 (en) * 2003-09-15 2005-03-24 Pfizer Products Inc. Methods for measuring peroxisome proliferation and peroxisomal induction
PT1909561E (pt) 2005-07-25 2010-05-06 Basf Se Método de apresentação e análise de uma população animal com um metaboloma essencialmente idêntico
AU2006274029B2 (en) * 2005-07-25 2011-07-14 Metanomics Gmbh Means and methods for analyzing a sample by means of chromatography-mass spectrometry
US20070037193A1 (en) * 2005-08-12 2007-02-15 Rong-Hwa Lin Modulation of peroxisome proliferator-activated receptors
US20070265216A1 (en) * 2005-10-05 2007-11-15 Gross Richard W Enhanced medical treatment in diabetic cardiomyopathy
WO2007110357A2 (en) * 2006-03-24 2007-10-04 Metanomics Gmbh Means and method for diagnosing diabetes
US20080176266A1 (en) * 2006-08-17 2008-07-24 Alvin Berger Biomarkers Of Metabolic Responses To Hepatotoxicants And Carcinogens
EP2286245A2 (en) * 2008-05-28 2011-02-23 Basf Se Means and methods for assessing increased peroxisomal proliferation

Also Published As

Publication number Publication date
DE112009001301T5 (de) 2011-06-09
JP5584680B2 (ja) 2014-09-03
AU2009259543A1 (en) 2009-12-23
US20160169863A1 (en) 2016-06-16
US9304136B2 (en) 2016-04-05
EP2286245A2 (en) 2011-02-23
CA2724422A1 (en) 2009-12-23
WO2009153139A2 (en) 2009-12-23
AU2009259543B2 (en) 2015-09-03
US8658427B2 (en) 2014-02-25
JP2011523708A (ja) 2011-08-18
US20110129933A1 (en) 2011-06-02
CN102105797A (zh) 2011-06-22
US20140186964A1 (en) 2014-07-03
WO2009153139A3 (en) 2010-02-18

Similar Documents

Publication Publication Date Title
BRPI0917910A2 (pt) método para detectar amostra de aspereza e aparelho para o método
BR112012002954A2 (pt) metodo para diagnosticar um disturbio de tireoide, metodo para determinar a capacidade de um composto de induzir um disturbio da tireoide metodo para identificar uma substancia para tratar um disturbio da tireoide, dispositivo para diagnosticar um disturbio da tireoide e uso de pelo menos um analito
BRPI0909361A2 (pt) subconjunto sensor de analito e métodos e aparelhos para inserir um sensor de analito associado com o mesmo
BRPI0918101A2 (pt) método para medir a troponina i em uma amostra, cartucho para ser utilizado em um dispositivo de ensaio e uso
BRPI0911863A2 (pt) método para determinar a presença de um analito em uma amostra de estrutura queratinizada de um indivíduo.
BRPI0812244A2 (pt) Método e aparelho para perfilagem de poço por rmn de alta relação sinal-ruído
BRPI0912110A2 (pt) métodos para diagnosticar a toxicidade do fígado, para determinar se um composto é capaz de induzir a toxicidade no fígado em um indivíduo, e para identificar uma substância para tratar toxicidade do fígado
BRPI1006595A2 (pt) tira de teste e método para detectar a presença de um análito em uma amostra
HUE058823T2 (hu) Rendszer és eljárás elektrokémiai analitérzékelõ mûködtetésére
BRPI0921017A2 (pt) métodos para testar uma estação base, e para determinar a configuração de uma estação base, aparelho de teste, estação base, e, aparelho para testar uma estação base
BRPI0921997A2 (pt) dispositivo para medição do componente de sangue.
BRPI1015211A2 (pt) cartucho de teste microfluídico descartável para o bioensaio de analitos
BRPI0720361A2 (pt) Método para medir aglutinação de uma ou mais partículas em um ensaio de aglutinação induzida por alvo efetuado em uma câmara de reação, e, kit e dispositivo para medir um ou mais parâmetros de aglutinação de partículas em um ensaio de aglutinação induzida por alvo
BRPI0914801A2 (pt) método para detectar o grupo sanguíneo abo/rh/mn humano, e, kit
BRPI0913469A2 (pt) método para a realização de um ensaio de aglomerado, aparelho para a realização de um ensaio de aglomerado, uso de um método e uso de um aparelho
BRPI0915240A2 (pt) método para tratar câncer, método para avaliação de um paciente submetido ao tratamento de câncer, método para avaliação de um paciente que tem ou com suspeita de ter câncer e uso de um anticorpo anti-c-met
BR112015009901A2 (pt) elementos de ensaio , material reagente e método para a determinação dos primeiro e segundo analitos em uma amostra.
BRPI0922085A2 (pt) método para manufaturar uma função de teste de sujeira ou desgaste em um documento de valor, documento de valor, em método e aparelho para detectar sujeira ou desgaste de um documento de valor
BRPI0906907A2 (pt) Carreador para a detecção óptica em uma amostra em uma câmara de amostra adjacente e aparelho para a detecção óptica em uma amostra em uma câmara de amostra.
BRPI0912210A2 (pt) dispositivo para medição e gerenciamento de analito e métodos associados
BRPI0910030A2 (pt) método de teste ultra-sônico e equipamento para o mesmo.
BRPI0918842A2 (pt) método para tratar pacientes com esclerose múltipla com anticorpos anti-il2r
BRPI0820721A2 (pt) Reagentes e métodos para detectar analitos
BR112013000017A2 (pt) mátodo para exame de uma amostra em um cartucho com uma entrada e uma câmara de reação, cartucho para exame de uma amostra e aparalho para exame de uma amostra
BRPI0815710A2 (pt) Método e aparelho para analisar características de uma formação subterrânea.

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2465 DE 03-04-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.